Bolivia, Plurinational State of vs Mali: Average cost of multi drug-resistant tuberculosis treatment
Bolivia, Plurinational State of
753 constant 2022 US$
in 2024
Mali
709 constant 2022 US$
in 2024
Bolivia, Plurinational State of rank
65th
Mali rank
67th
Average cost of multi drug-resistant tuberculosis treatment over time
- Bolivia, Plurinational State of
- Mali
How they compare
Bolivia, Plurinational State of currently reports 753 constant 2022 US$ against 709 constant 2022 US$ in Mali, a difference of 44 constant 2022 US$.
That makes Bolivia, Plurinational State of's figure about 1.1 times Mali's.
The two have swapped places 2 times across 6 shared years of data; in 2017 it was Bolivia, Plurinational State of ahead.
Bolivia, Plurinational State of ranks 65th and Mali ranks 67th of 92 countries.
Mali has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bolivia, Plurinational State of | Mali | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2,506 constant 2022 US$ | 5,465 constant 2022 US$ | 2,959 constant 2022 US$ | Mali |
| 2020s | 717.33 constant 2022 US$ | 22,706 constant 2022 US$ | 21,988 constant 2022 US$ | Mali |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, Bolivia, Plurinational State of or Mali?
- Bolivia, Plurinational State of, at 753 constant 2022 US$ against 709 constant 2022 US$ in Mali as of 2024.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between Bolivia, Plurinational State of and Mali?
- 44 constant 2022 US$, with Bolivia, Plurinational State of ahead.
- How many years of comparable data are there for Bolivia, Plurinational State of and Mali?
- 6 years are reported by both, from 2017 to 2024.
- How do Bolivia, Plurinational State of and Mali rank globally for average cost of multi drug-resistant tuberculosis treatment?
- Bolivia, Plurinational State of ranks 65th and Mali ranks 67th of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.